Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Thyroid Meds Recalled Nationwide; Life Expectancy Rebounds; Cannabis Use Hits Record

Health news and commentary gathered by MedPage Today staff

The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify

The $50 price under the program applies only to people using the drug solely for weight loss

'Gray Market' Retatrutide Study; Menopause and the Brain; Drug Allergy Warnings

News and commentary from the endocrinology world

FDA Authorizes First Wearable Dual Glucose-Ketone Sensor

System offers real-time diabetic ketoacidosis warnings

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Todays Updates

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

More Evidence Ties Microplastics to Lung Cancer

Observational study shows greater microplastic burden in patients with lung malignancy

Nationwide Epinephrine Recall; FBI's Fauci Probe; Bruce Campbell's Cancer

Health news and commentary gathered by MedPage Today staff

9/11's Latest Wave of Cancers, 25 Years On

The health ramifications of the attack persist

Latest News

Current and Emerging Strategies for Addressing IAH and Recurrent Severe Hypoglycemia in T1D

Navigating Advances in Obesity Management: Amylin-Biology and Emerging Therapeutic Approaches

Health news and commentary gathered by MedPage Today staff

The $50 price under the program applies only to people using the drug solely for weight loss

News and commentary from the endocrinology world

System offers real-time diabetic ketoacidosis warnings

News All Time

Endometriosis Can Elude Diagnosis for Years. What to Know About New Ways to Find It.

New tests available abroad are raising hope among doctors and patients

New GLP-1 Hair Loss Insights; Wegovy in Kids; Are Fitness Trackers Lying to Users?

News and commentary from the endocrinology world

Preschoolers With Cystic Fibrosis Get Close to Normal on Alyftrek

TIMBERLINE study shows good safety and sweat chloride reductions with triple combo CFTR modulator

Menopausal Hormone Therapy May Ease Severe Mood Symptoms

Therapy also associated with better sleep scores in non-controlled study

The CDC Division I Spent 15 Years Building Is in Peril

Cuts to the Division of Nutrition, Physical Activity, and Obesity will not make America healthy

The Market Forces Quietly Adding Thousands to Patient Bills

A look at a shifting industry

Preserving Muscle During GLP-1 Weight Loss

Experts advise tracking body composition, boosting protein, and resistance training

Early T1D Screening Guide; FDA Clears Mint Patch Pump; GLP-1s and Fertility

News and commentary from the endocrinology world

ADA Boycott Follows Meeting Scandal; Lawsuits Fly in Residency Application Space

MedPage Today reporters offer further insights into recently covered topics

Pentagon Revives Testosterone Testing After Pause, Excludes Women

The Pentagon is reinstituting a mandatory testing program for testosterone deficiency among US service members age 30 and older, a spokesperson ⁠said on Thursday, bringing...

Osteoporosis: Are Bone Density Targets Worth Chasing?

Specialists debate the value of specific bone density goals with concerns that measurement variability and limited trial evidence may complicate treatment decisions.

GLP-1 Systematic Review Finds Weight Loss of Up to 24%

GLP-1 drugs are associated with substantial weight loss in adults without diabetes, and the range of options, including oral and multiagonist therapies, is expanding.

Nurse-Led Digital Therapeutics Boosts Diabetes Outcomes

A structured nurse-led digital therapeutics pathway is linked to higher adherence and more favorable metabolic outcomes than usual care in adults with type 2 diabetes, a study reports.

FDA Approves Generic Lutathera for Adults With GEP-NETs

Bexlutry is the first radioligand equivalent approved by the agency for treatment of the rare tumors.

Could Psilocybin Prevent Nerve Damage From Chemotherapy?

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are still needed to determine whether it benefits patients.

Body-Related TikTok Reels Tied to Self-Objectification, Mood

Viewing appearance-focused TikTok videos is associated with increased self-objectification in women, as well as changes in mood.

Recommended News For You

In cases of locally advanced, potentially curable pancreatic cancer, a combination of drugs enhances the results of radiation therapy.

Oncology Care Model’s Net Losses Well Exceed Savings

Specific suicidal patterns mark the highest risk.

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

Number of cancer survivors in the US reaches 18.6 million—projected to exceed 22 million by 2035

AVD Chemo Regimen Shows Promise in Older Patients With HL

Data indicate 1 in 3 US adults unaware of connection between HPV and cancers

Recommended Articles For You

First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care 

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients 

Artificial Intelligence for Hematopoietic Cell Lineage Dynamics Prediction 

Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer

2.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

3.

In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.

4.

Survey: Record Numbers of US Adults Report Depression.

5.

FDA Approves Hemophilia B Second Gene Therapy.

1.

Unlocking a New Era in Bladder Cancer Treatment: A Review of the TAR-200 Intravesical Drug Delivery System

2.

Ear Emergency: Understanding the Causes and Treatment for Auricular Hematoma

3.

Modern Concepts in Oncology Across Clinical Settings

4.

Rehabilitation of Functional Capacity Following Cancer-Related Prolonged Deconditioning

5.

Learning from Uncommon Inherited Bleeding Disorder Presentations

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

How Hematologists Evaluate Persistent Blood Abnormalities

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII

3.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

5.

Early Cancer Detection Saves Lives

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot